Meta-analysis of the therapeutic effects of traumatic BPPV and idiopathic BPPV
-
By
-
Yifei Fu
-
Zhibin Zhao
-
June 9, 2026
Clinical Report: Treatment Outcomes in Traumatic Versus Idiopathic BPPV
Overview
This systematic review evaluates the treatment efficacy and prognosis differences between traumatic benign paroxysmal positional vertigo (t-BPPV) and idiopathic BPPV (i-BPPV). Findings indicate that t-BPPV has significantly poorer outcomes, including higher recurrence rates and repositioning difficulties.
Background
Benign paroxysmal positional vertigo (BPPV) is a prevalent vestibular disorder that significantly impacts patients' quality of life. Understanding the differences in treatment outcomes between t-BPPV and i-BPPV is crucial for optimizing management strategies. This study addresses the need for high-level evidence to guide clinical practice in treating these distinct forms of BPPV.
Data Highlights
| Outcome | RR (95% CI) | p-value |
|---|---|---|
| Recurrence Rate | 3.39 (3.07–3.74) | < 0.00001 |
| Repositioning Difficulty | 3.05 (2.74–3.40) | < 0.00001 |
| Treatment Efficacy | 0.87 (0.84–0.90) | < 0.00001 |
| Multi-Semicircular Canal Involvement | 2.91 (1.55–5.47) | 0.0009 |
| Bilateral BPPV Incidence | 3.37 (1.86–6.10) | < 0.00001 |
Key Findings
- t-BPPV has a significantly higher recurrence rate compared to i-BPPV (RR = 3.39).
- Patients with t-BPPV experience greater repositioning difficulty (RR = 3.05).
- The treatment efficacy for t-BPPV is lower than for i-BPPV (RR = 0.87).
- There is a higher proportion of multi-semicircular canal involvement in t-BPPV (RR = 2.91).
- t-BPPV shows an elevated incidence of bilateral BPPV (RR = 3.37).
Clinical Implications
Clinicians should recognize that t-BPPV presents unique challenges compared to i-BPPV, necessitating tailored management strategies. Long-term follow-up and personalized interventions are essential for improving outcomes in patients with t-BPPV.
Conclusion
The findings underscore the need for differentiated treatment approaches for t-BPPV due to its poorer prognosis compared to i-BPPV. Enhanced understanding of these differences can lead to better patient management and care.
Related Resources & Content
- Frontiers in Neurology, 2026 -- Risk factors for refractory BPPV: subtype-dependent association of serum 25-hydroxyvitamin D
- DIGITAL HEALTH, 2026 -- Analysis of the quality and reliability of benign paroxysmal positional vertigo-related short videos on TikTok and Bilibili: A cross-sectional study
- Utilization of Auditory Brainstem Responses in Diagnosing Neurovascular Compression of the Eighth Cranial Nerve in Vestibular Paroxysmia
- Journal of Neuro-Oncology, 2024 -- Tinnitus Following Vestibular Schwannoma Treatment: A Systematic Review and Comparative Study of Microsurgical and Stereotactic Radiosurgical Approaches
- AAO-HNS Benign Paroxysmal Positional Vertigo Guideline Summary - Guideline Central
- Frontiers, 2026 -- Meta-analysis of the therapeutic effects of traumatic BPPV and idiopathic BPPV
- Position Statement: Vestibular Rehabilitation - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)
- AAO-HNS Clinical Practice Guideline on BPPV
- Frontiers | Meta-analysis of the therapeutic effects of traumatic BPPV and idiopathic BPPV
- Position Statement: Vestibular Rehabilitation - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.